3-acetyl-6-chloro-4-(4-chlorophenyl)quinolin-2(1H)-one, 95.0%, 500mg

1-Benzylpiperidine-2-carboxylic acid, 95.0%, 100g

1,3-Butanediol, min. 99%, for synthesis, 250 ml, plastic packaging.

1,2,3,4-Tetrahydroquinoline-6-carboxylic acid, 95.0%, 1g

(E)-ETHYL 2-(1-CARBAMOYL-2-((5-NITROFURAN-2-YL)METHYLENE)HYDRAZINYL)ACETATE, 90.0%, 100mg

(4-Methyl-thiazol-2-ylsulfanyl)-acetic acid, 95.0%, 25g

4-CHLORO-2-(TRIFLUOROMETHOXY)BENZOIC ACID, 95.0%, 25g

1-((Prop-2-yn-1-yloxy)methyl)pyrene, 98%, 250mg

2,6-Dibromo-4-(trifluoromethyl)pyridine, 95.0%, 5g

Ethyl 4-(3,4-dimethylphenyl)-4-oxobutyrate, 97.0%, 2g

4-Bromo-2-pyridinemethanol>98.0%(GC)1g

9-(Naphthalen-1-yl)-10-(4-(naphthalen-2-yl)phenyl)anthracene, 98%, 100g

(S)-1-(3,4-DIMETHOXYPHENYL)ETHYLAMINE, 95.0%, 250mg